Epidemiologic evidence suggests that dietary phytoestrogen intake is associated with reduced risk of breast, endometrial, and prostate cancers

Nutrition Research

Volumn 26, Issue 12, 2006, Pages 609-619

  Lof, Marie ^a   Weiderpass, Elisabete ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Breast cancer; Endometrial cancer; Epidemiology; Phytoestrogens; Prostate cancer

Indexed keywords

DAIDZEIN; ENTEROLACTONE; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHYTOESTROGEN;

ANTIOXIDANT ACTIVITY; BLOOD PRESSURE MEASUREMENT; BODY MASS; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; DIETARY INTAKE; ENDOMETRIUM CANCER; GENE INTERACTION; HORMONE BLOOD LEVEL; HUMAN; MEDICAL LITERATURE; NUTRIENT AVAILABILITY; NUTRIENT CONTENT; PREMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION; QUALITATIVE RESEARCH; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SOYBEAN; STATISTICAL SIGNIFICANCE; URINARY EXCRETION;

EID: 33845400991     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.09.020     Document Type: Review

References (77)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 3 6 (2002) 364-373
3. Heinonen S., Nurmi T., Liukkonen K., Poutanen K., Wahala K., Deyama T., et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49 7 (2001) 3178-3186
4. Mazur W., and Adlercreutz H. Overview of naturally occurring endocrine-active substances in the human diet in relation to human health. Nutrition 16 7-8 (2000) 654-658
5. Magee P., and Rowland I. Phytoestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 94 (2004) 513-531
6. Mueller S.O., Simon S., Chae K., Metzler M., and Korach K.S. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80 1 (2004) 14-25
7. Lian Z., Niwa K., Tagami K., Hashimoto M., Gao J., Yokoyama Y., et al. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn J Cancer Res 92 7 (2001) 726-734
8. Mazur W. Phytoestrogen content in foods. In: Adlercreutz H. (Ed). Phytoestrogens. Bailliere's Clin Endocrinol Metab (1998), Bailliere Tindall, London 729-742
9. Horn-Ross P.L., Barnes S., and Lee M. Assessing phytoestrogen exposure in epidemiological studies: development of a database (United States). Cancer Causes Control 11 (2000) 289-298
10. Peeters P.H., Keinan-Boker L., van der Schouw Y.T., and Grobbee D.E. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 77 2 (2003) 171-183
11. Boccardo F., Puntoni M., Guglielmini P., and Rubagotti A. Enterolactone as a risk factor for breast cancer: a review of the published evidence. Clin Chim Acta 365 1-2 (2006) 58-67
12. McCann M.J., Gill C.I., McGlynn H., and Rowland I.R. Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr Cancer 52 1 (2005) 1-14
13. Zheng W., Dai Q., Custer L.J., Shu X.O., Wen W.Q., Jin F., et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8 1 (1999) 35-40
14. Dai Q., Franke A.A., Jin F., Shu X.O., Hebert J.R., Custer L.J., et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11 9 (2002) 815-821
15. Hirohata T., Shigematsu T., Nomura A., Nomura Y., Horie A., and Hirohata I. Occurrence of breast cancer in relation to diet and reproductive history: a case control study in Fukuoka, Japan. Natl Cancer Inst Monogr 69 (1985) 187-190
16. Nomura A., Henderson B.E., and Lee J. Breast cancer and diet among the Japanese in Hawaii. Am J Clin Nutr 31 11 (1978) 2020-2025
17. Murkies A., Dalais F.S., Briganti E.M., Burger H.G., Healy D.L., Wahlqvist M.L., et al. Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 7 5 (2000) 289-296 [see comment]
18. Lee H.P., Gourley L., Duffy S.W., Esteve J., Lee J., and Day N.E. Dietary effects on breast-cancer risk in Singapore. [see comment]. Lancet 337 8751 (1991) 1197-2000
19. Hirose K., Tajima K., Hamajima N., Inoue M., Takezaki T., Kuroishi T., et al. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86 2 (1995) 146-154
20. Yuan J.M., Wang Q.S., Ross R.K., Henderson B.E., and Yu M.C. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71 6 (1995) 1353-1358
21. Wu A.H., Ziegler R.G., Horn-Ross P.L., Nomura A.M., West D.W., Kolonel L.N., et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5 11 (1996) 901-906
22. Wu A., Wan P., Hankin J., Tseng C., Yu M., and Pike M. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23 (2002) 1491-1496
23. Greenstein J., Kushi L., and Zheng W. Risk of breast cancer associated with intake of specific foods and food groups. [abstract]. Am J Epidemiol 143 S36 (1996)
24. Ingram D., Sanders K., Kolybaba M., and Lopez D. Case-control study of phyto-oestrogens and breast cancer. [see comment]. Lancet 350 9083 (1997) 990-994
25. Witte J.S., Ursin G., Siemiatycki J., Thompson W.D., Paganini-Hill A., and Haile R.W. Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat 42 3 (1997) 243-251
26. Chie W., Lee W., Li C., Huang C., and Lin R. Soybean products, vegetable and fruit and breast cancer risk in Taiwan. Breast Cancer Res Treat 46 (1997) 80
27. Key T.J., Sharp G.B., Appleby P.N., Beral V., Goodman M.T., Soda M., et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 81 7 (1999) 1248-1256
28. Dai Q., Shu X.O., Jin F., Potter J.D., Kushi L.H., Teas J., et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85 3 (2001) 372-378
29. Shu X.O., Jin F., Dai Q., Wen W., Potter J.D., Kushi L.H., et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 10 5 (2001) 483-488
30. Horn-Ross P.L., John E.M., Lee M., Stewart S.L., Koo J., Sakoda L.C., et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154 5 (2001) 434-441
31. den Tonkelaar I., Keinan-Boker L., Veer P.V., Arts C.J., Adlercreutz H., Thijssen J.H., et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10 3 (2001) 223-228
32. Horn-Ross P.L., Hoggatt K.J., West D.W., Krone M.R., Stewart S.L., Anton H., et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13 5 (2002) 407-415
33. Yamamoto S., Sobue T., Kobayashi M., Sasaki S., Tsugane S., and Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases Group. Soy, isoflavones, and breast cancer risk in Japan. [see comment]. J Natl Cancer Inst 95 12 (2003) 906-913
34. Linseisen J., Piller R., Hermann S., and Chang-Claude J. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 110 2 (2004) 284-290
35. Grace P.B., Taylor J.I., Low Y.L., Luben R.N., Mulligan A.A., Botting N.P., et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 13 5 (2004) 698-708
36. Keinan-Boker L., van Der Schouw Y.T., Grobbee D.E., and Peeters P.H. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79 2 (2004) 282-288 [see comment]
37. Peterson J., Lagiou P., Samoli E., Lagiou A., Katsouyanni K., La Vecchia C., et al. Flavonoid intake and breast cancer risk: a case-control study in Greece. Br J Cancer 89 7 (2003) 1255-1259
38. Bosetti C., Spertini L., Parpinel M., Gnagnarella P., Lagiou P., Negri E., et al. Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14 4 (2005) 805-808
39. dos Santos Silva I., Mangtani P., McCormack V., Bhakta D., McMichael A.J., and Sevak L. Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study. Cancer Causes Control 15 8 (2004) 805-818
40. Piller R., Chang-Claude J., and Linseisen J. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 15 3 (2006) 225-232
41. Trock B., Hilakivi-Clarke L., and Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98 (2006) 459-471
42. McCann S.E., Moysich K.B., Freudenheim J.L., Ambrosone C.B., and Shields P.G. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 132 10 (2002) 3036-3041
43. McCann S.E., Muti P., Vito D., Edge S.B., Trevisan M., and Freudenheim J.L. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 111 3 (2004) 440-443
44. McCann S., Kulkarni S., Trevisan M., Vito D., Nie J., Edge S.B., et al. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 99 3 (2006) 309-311
45. Pietinen P., Stumpf K., Mannisto S., Kataja V., Uusitupa M., and Adlercreutz H. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10 4 (2001) 339-344
46. Hulthen K., Winkvist A., Lenner P., Johansson R., Adlercreutz H., and Hallmans G. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 41 4 (2002) 168-176
47. Kilkkinen A., Virtamo J., Vartiainen E., Sankila R., Virtanen M.J., Adlercreutz H., et al. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 108 2 (2004) 277-280
48. Boccardo F., Lunardi G., Guglielmini P., Parodi M., Murialdo R., Schettini G., et al. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40 1 (2004) 84-89
49. Olsen A., Knudsen K.E., Thomsen B.L., Loft S., Stripp C., Overvad K., et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 13 12 (2004) 2084-2089
50. Goodman M.T., Wilkens L.R., Hankin J.H., Lyu L.C., Wu A.H., and Kolonel L.N. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146 4 (1997) 294-306
51. Horn-Ross P.L., John E.M., Canchola A.J., Stewart S.L., and Lee M.M. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95 15 (2003) 1158-1164
52. Xu W.H., Zheng W., Xiang Y.B., Ruan Z.X., Cheng J.R., Dai Q., et al. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 328 7451 (2004) 1285
53. Zeleniuch-Jacquotte A., Lundin E., Micheli A., Koenig K.L., Lenner P., Muti P., et al. Circulating enterolactone and risk of endometrial cancer. Int J Cancer 119 10 (2006) 2376-2381
54. Sung J.F., Lin R.S., Pu Y.S., Chen Y.C., Chang H.C., and Lai M.K. Risk factors for prostate carcinoma in Taiwan: a case-control study in a Chinese population. Cancer 86 3 (1999) 484-491
55. Villeneuve P.J., Johnson K.C., Kreiger N., and Mao Y. Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 10 5 (1999) 355-367
56. Sonoda T., Nagata Y., Mori M., Miyanaga N., Takashima N., Okumura K., et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci 95 3 (2004) 238-242
57. Lee M.M., Gomez S.L., Chang J.S., Wey M., Wang R.T., and Hsing A.W. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12 7 (2003) 665-668
58. Kolonel L.N., Hankin J.H., Whittemore A.S., Wu A.H., Gallagher R.P., Wilkens L.R., et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9 8 (2000) 795-804
59. Nomura A.M., Hankin J.H., Lee J., and Stemmermann G.N. Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol Biomarkers Prev 13 12 (2004) 2277-2279
60. Jacobsen B.K., Knutsen S.F., and Fraser G.E. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9 6 (1998) 553-557 [see comment]
61. Severson R.K., Nomura A.M., Grove J.S., and Stemmermann G.N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49 7 (1989) 1857-1860
62. Ozasa K., Nakao M., Watanabe Y., Hayashi K., Miki T., Mikami K., et al. Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95 1 (2004) 65-71
63. Strom S.S., Yamamura Y., Duphorne C.M., Spitz M.R., Babaian R.J., Pillow P.C., et al. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer 33 1 (1999) 20-25
64. Hedelin M., Klint Å., Chang E., Bellocco R., Johansson J.E., Andersson S.O., et al. Dietary phytoestrogen, serum enterolactone, and risk of prostate cancer: the Cancer Prostate Sweden Study. Cancer Causes Control 17 (2005) 169-180
65. Yan L., and Spitznagel E.L. Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117 4 (2005) 667-669
66. Stattin P., Adlercreutz H., Tenkanen L., Jellum E., Lumme S., Hallmans G., et al. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 99 1 (2002) 124-129
67. Stattin P., Bylund A., Biessy C., Kaaks R., Hallmans G., and Adlercreutz H. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 15 10 (2004) 1095-1102
68. Kilkkinen A., Virtamo J., Virtanen M.J., Adlercreutz H., Albanes D., and Pietinen P. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 12 11 Pt 1 (2003) 1209-1212
69. Kilkkinen A., Pietinen P., Klaukka T., Virtamo J., Korhonen P., and Adlercreutz H. Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155 5 (2002) 472-477
70. Zeleniuch-Jacquotte A., Adlercreutz H., Shore R.E., Koenig K.L., Kato I., Arslan A.A., et al. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 91 1 (2004) 99-105
71. Seo H.S., DeNardo D., Jacquot Y., Laios I., Salazar Vidal D., Rojas C., et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 99 2 (2006) 121-134
72. Touilland M.S., Pillow P.C., Jakovljevic J., Bondy M.L., Singletary S.E., Li D., et al. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 51 2 (2005) 162-169
73. Demark-Wahnefried W., Price D.T., Polascik T.J., Robertson C.N., Anderson E.E., Paulson D.F., et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58 1 (2001) 47-52
74. Bylund A., Lundin E., Zhang J.X., Nordin A., Kaaks R., Stenman U.H., et al. Randomised controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev 12 5 (2003) 407-415
75. Low Y.L., Taylor J.I., Grace P.B., Dowsett M., Scollen S., Dunning A.M., et al. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Cancer Epidemiol Biomarkers Prev 14 1 (2005) 213-220
76. Thellenberg-Karlsson C., Lindstrom S., Malmer B., Wiklund F., Augustsson-Balter K., Adami H.O., et al. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res 12 6 (2006) 1936-1941
77. Hedelin M., Augustsson Balter K., Chang E., Bellocco R., Klint Å., Johansson J.-E., et al. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 66 14 (2006) 1512-1520